SYGNIS AG announced that the Supervisory Board has resolved important changes and additions to the senior management team to better align the organisational structure with the strategic goals of the company in terms of corporate growth. The Supervisory Board has appointed Daniel Roth as the new Chief Financial Officer of the company, with effect from 1 March 2017. Pilar de la Huerta continues to contribute her expertise to the company, remaining Co-CEO together with Dr. Heikki Lanckriet, and additionally assuming a new role as the company's Chief Business Development Officer (CBDO).

David Roth, a native German living in the UK, has over 20 years financial management experience with a special focus on the healthcare sector. He is a chartered accountant having worked with KPMG, Deloitte and Arthur Andersen in the UK where he became a director and partner within the audit and advisory practice. Here he acted for a wide range of clients, including biotech companies as well as advising listed companies both in the UK and the US.

More recently, he acted as CFO of several international organisations, all of them high-growth healthcare businesses, leading financial and operational teams. His responsibilities included a $100 million secondary NASDAQ listing and subsequent reporting roles, as well as analysis and financial support in several business acquisitions and corporate transactions. In his role as Chief Financial Officer at SYGNIS he will be in charge of the financial strategy and accounting processes.